Has Srinivas Dukkipati, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,710,164 in general payments to Srinivas Dukkipati, MD across 138 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Srinivas Dukkipati, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Srinivas Dukkipati, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Srinivas Dukkipati, MD

Clinical Cardiac Electrophysiology · New York, NYNPI 1144259433

Payments from drug & device makers

What this record shows

This record is dominated by other: $2,630,490 of the $2,710,164 with a category attached, or 97.1%. Boston Scientific accounts for 99.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $1,298,214 and has fallen 98.2% since, to $22,828 in 2025. Among clinical cardiac electrophysiology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,710,164in general payments, 2019–2025

Across 138 payments — averaging $19,639 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Boston Scientific$2.7M
Medtronic$9K
Biosense Webster, Inc.$5K
Biotronik Inc.$5K
Abbott$1K
E.r. Squibb & Sons, L.L.C.$182
plus $334 from 6 others

$1,484,617in research payments, 2019–2025

Across 351 payments — averaging $4229.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Kardium Inc.$312K
Medtronic$294K
Boston Scientific$282K
Medical Device Business Services, Inc.$234K
Biosense Webster, Inc.$190K
Abbott$173K

What the payments were for

Consulting fees$5,8880%
Speaking & faculty fees$61,6752%
Grants$5,0000%
Travel & lodging$1,7020%
Food & beverage$5,4100%
Other$2,630,49097%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Boston Scientific	79	$2,689,788
Medtronic(2 entities)	14	$8,529
Biosense Webster, Inc.	8	$5,275
Biotronik Inc.	1	$5,000
Abbott	18	$1,056
E.r. Squibb & Sons, L.L.C.	8	$182
Cardiva Medical, Inc.	4	$124
Cardiofocus, Inc.	1	$58
Atricure, Inc.	2	$47
Irhythm Technologies, Inc.	1	$44
Johnson & Johnson	1	$37
Cordis US CORP.	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,710,164 in reported general payments places this provider in the 95th percentile of 214 clinical cardiac electrophysiology providers in New York.

See all clinical cardiac electrophysiology providers in New York →

Medicare billing

Part B allowed, 2024

$384,893

Medicare patients

1,971

Services billed

4,771

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	20	$19,054
Metoprolol Succinate	13	$63

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in New York

Vivek ReddyNew York$14.9M
Jacob KoruthNew York$3.7M
Amir AhmadiNew York$789K
Larry ChinitzNew York$448K
James IpNew York$347K
Nicholas SkipitarisNew York$293K
Mohit TuragamNew York$202K
David LauNew York$202K
Christopher LiuNew York$181K
Chirag BarbhaiyaNew York$156K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →